|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.98/-1.66
|
企業價值
22.87M
|
資產負債 |
每股賬面淨值
-0.33
|
現金流量 |
現金流量率
--
|
損益表 |
收益
4.49M
|
每股收益
0.21
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/12/23 22:18 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. |